Sustained virologic response after therapy with the HCV protease inhibitor narlaprevir in combination with peginterferon and ribavirin is durable through long-term follow-up. (Q42990108)
Jump to navigation
Jump to search
scientific article published on 7 January 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sustained virologic response after therapy with the HCV protease inhibitor narlaprevir in combination with peginterferon and ribavirin is durable through long-term follow-up. |
scientific article published on 7 January 2013 |
Statements
Sustained virologic response after therapy with the HCV protease inhibitor narlaprevir in combination with peginterferon and ribavirin is durable through long-term follow-up (English)
D M Hotho
J de Bruijne
M A Treitel
R J de Knegt
H L A Janssen
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference